Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy
- PMID: 17241753
- DOI: 10.1016/j.ijrobp.2006.10.043
Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy
Abstract
Purpose: To determine factors predictive of local-regional recurrence (LRR) after surgery alone for carcinomas of the major salivary glands in an attempt to evaluate the potential role of postoperative radiation therapy.
Methods and materials: Between 1960 and 2004, 207 patients with carcinomas of the major salivary glands were treated with definitive surgery without postoperative radiation therapy. Histology was: 67 mucoepidermoid (32%), 50 adenoid cystic (24%), 34 acinic cell (16%), 23 malignant mixed (11%), 16 adenocarcinoma (8%), 6 oncocytic (3%), 6 myoepithelial (3%), and 5 other (2%). Distribution of pathologic T-stage was: 54 T1 (26%), 83 T2 (40%), 46 T3 (22%), and 24 T4 (12%). Sixty patients (29%) had microscopically positive margins. Median follow-up was 6.1 years (range, 0.5-18.7 years).
Results: The 5-year and 10-year estimates of local-regional control were 86% and 74%, respectively. A Cox proportional hazard model identified pathologic lymph node metastasis (hazard ratio [HR], 4.8; p = 0.001), high histologic grade (HR, 4.2; p = 0.003), positive margins (HR, 2.6; p = 0.03), and T3-4 disease (HR, 2.0; p = 0.04) as independent predictors of LRR. The presence of any one of these factors was associated with 10-year local-regional control rates of 37% to 63%.
Conclusion: Lymph node metastasis, high tumor grade, positive margins, and T3-4 stage predict for significant rates of LRR after surgery for carcinomas of the major salivary glands. Postoperative radiation therapy should be considered for patients with these disease characteristics.
Similar articles
-
Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation?Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):988-94. doi: 10.1016/j.ijrobp.2006.10.044. Epub 2007 Jan 17. Int J Radiat Oncol Biol Phys. 2007. PMID: 17234357
-
Radiation therapy for patients of malignant salivary gland tumors with positive surgical margins.Strahlenther Onkol. 1994 Jun;170(6):342-6. Strahlenther Onkol. 1994. PMID: 8023243
-
Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas.Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1044-50. doi: 10.1016/j.ijrobp.2006.06.050. Epub 2006 Sep 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16965870
-
Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients.Oral Oncol. 2007 Feb;43(2):130-6. doi: 10.1016/j.oraloncology.2006.03.001. Epub 2006 Jul 20. Oral Oncol. 2007. PMID: 16857410 Review.
-
Mucoepidermoid carcinoma of minor salivary glands: a clinical study of 16 cases and review of the literature.Oral Dis. 2006 Jul;12(4):364-70. doi: 10.1111/j.1601-0825.2005.01166.x. Oral Dis. 2006. PMID: 16792720 Review.
Cited by
-
Outcomes and prognostic factors in modern era management of major salivary gland cancer.Oral Oncol. 2015 Aug;51(8):770-7. doi: 10.1016/j.oraloncology.2015.05.005. Epub 2015 May 29. Oral Oncol. 2015. PMID: 26033470 Free PMC article.
-
Clinical Prediction Nomograms to Assess Overall Survival and Disease-Specific Survival of Patients with Salivary Gland Adenoid Cystic Carcinoma.Biomed Res Int. 2022 Aug 29;2022:7894523. doi: 10.1155/2022/7894523. eCollection 2022. Biomed Res Int. 2022. PMID: 36072473 Free PMC article.
-
[Surgery for parotid gland cancer-controversial and proven aspects].HNO. 2023 Apr;71(4):215-222. doi: 10.1007/s00106-022-01182-w. Epub 2022 May 17. HNO. 2023. PMID: 35579674 Review. German.
-
Locally Advanced Stage High-Grade Mucoepidermoid Carcinoma of Salivary Gland in a 9-Year-Old Girl: The Controversy of Adjuvant Therapy.Rare Tumors. 2016 Oct 6;8(3):6429. doi: 10.4081/rt.2016.6429. eCollection 2016 Sep 5. Rare Tumors. 2016. PMID: 27746885 Free PMC article.
-
Overall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands: Analysis of 2210 patients.World J Clin Oncol. 2020 Dec 24;11(12):1029-1044. doi: 10.5306/wjco.v11.i12.1029. World J Clin Oncol. 2020. PMID: 33437665 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical